Latest news
Claris Biotherapeutics - The Pharma LetterThe Pharma Letter · Wed, 05 Aug 2026 13:34:20 GMTClaris Bio raises $118M to advance first-ever LSCD therapy - Glance by Eyes On EyecareGlance by Eyes On Eyecare · Mon, 03 Aug 2026 19:26:06 GMTClaris Bio Raises $118M to Take Eye Drop for Blindness into Phase III - Inside Precision MedicineInside Precision Medicine · Wed, 29 Jul 2026 18:58:34 GMTThe Escalator: AbbVie, Sarepta Therapeutics, OptimizeRx and more - Medical Marketing and MediaMedical Marketing and Media · Wed, 29 Jul 2026 13:04:21 GMTClaris Bio raises USD 118m to advance first-ever pharmacologic therapy for limbal stem cell deficiency - AllSciAllSci · Tue, 28 Jul 2026 15:48:38 GMT‘This could be a large market’: Novo Holdings-backed Claris secures $118M for corneal disease drug - Fierce BiotechFierce Biotech · Tue, 28 Jul 2026 12:28:31 GMTClaris collects $118M to take eye drop into pivotal testing next year - Endpoints NewsEndpoints News · Tue, 28 Jul 2026 12:00:00 GMTAn eye drug biotech banks $118M and stocks its executive suite - BioPharma DiveBioPharma Dive · Tue, 28 Jul 2026 07:00:00 GMT